Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief

ROANOKE, Va., Feb. 21, 2026 / PRZen / Capsadyn®, a non-burning capsaicin cream developed by Chorda Pharma Inc., is now available for purchase on Amazon in addition to direct-to-consumer sales through Capsadyn.com. The Amazon launch expands access to Capsadyn’s topical pain relief formula for customers seeking an alternative to traditional capsaicin creams that often cause skin irritation.

Capsadyn was developed to address the burning often linked to traditional capsaicin creams. In a randomized, double-blind clinical study, Capsadyn’s maximum-strength 0.25% formula demonstrated no meaningful difference in burning sensation compared with a placebo cream containing no capsaicin. Unlike many topical pain relief products, Capsadyn contains no steroids, NSAIDs, or anesthetics.

Traditional capsaicin creams are widely used for temporary relief of minor arthritis, joint, and muscle pain, but burning and discomfort can limit long-term use. Capsadyn, the strongest capsaicin cream available over the counter, was developed to help overcome this challenge by delivering effective capsaicin pain relief without the burn commonly associated with conventional formulas.

Because the formula is highly concentrated, a small amount is intended to deliver relief, with each jar providing approximately 50 applications depending on individual use. Capsadyn’s odorless, fast-absorbing, non-greasy formula is designed to be convenient and easy to use.

“Capsadyn is a gentle cream that safely and effectively treats joint and muscle pain,” says CEO Victor Iannello, ScD. “Now that it’s available on Amazon, more pain sufferers can benefit from this innovation in pain management.”

Capsadyn is manufactured in the United States in accordance with FDA regulations for external analgesics.

For more information, visit Capsadyn.com, or find Capsadyn on Amazon at https://www.amazon.com/dp/B0G2TCNTSV

About Capsadyn®

Capsadyn is an over-the-counter topical analgesic cream formulated with maximum-strength capsaicin (0.25%) and designed to provide temporary relief from minor arthritis, joint, and muscle pain without the burning sensation often associated with traditional capsaicin creams.

Press Release Distributed by PRLog

Source: Chorda Pharma Inc.

Follow the full story here: https://przen.com/pr/33606189